CVR: 37450308
DKK 266,924
Gross profit
Net result: DKK 23,513
No owners listed
CVR · view ownership and management
Director role ended: Jon Bjarke Kiellberg
CVR · 02/03/2020
View the full event history
Re cph IVS was a Danish company of the type Iværksætterselskab based in Frederiksberg C, founded in 2016 and dissolved in 2021. The company was registered under the industry Konsulentbistand vedrørende informationsteknologi. The company has 0 employees (2018). In 2018, the company reported a gross profit of DKK 266,924 and a net result of DKK 23,513 compared with DKK 220,160 the year before. Equity in the 2018 report amounted to DKK 91,148.
Screen owners and management against the Danish FSA's official PEP lists
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationNo. Re cph IVS is registered in the Danish CVR register with the status Dissolved and ceased on 28 September 2021.
Re cph IVS was founded on 3 February 2016.
Re cph IVS was registered under the industry Konsulentbistand vedrørende informationsteknologi (industry code 620200).
Re cph IVS had 0 employees in 2018 according to the Danish CVR register.
In 2018, Re cph IVS reported a gross profit of DKK 266,924.
Re cph IVS was located at Alhambravej 18, 1826 Frederiksberg C.
Re cph IVS was dissolved on September 28, 2021.
As of March 2, 2020, Jon Bjarke Kiellberg has stepped down as director of Re cph IVS.
Re cph IVS has published its annual report for 2018. Gross profit came to DKK 266,924, and the net result was DKK 23,513.
Re cph IVS has published its annual report for 2017. Gross profit came to DKK 518,634, and the net result was DKK 220,160.
Re cph IVS has published its annual report for 2016. Gross profit came to DKK 149,666, and the net result was DKK -152,527.
As of December 31, 2016, Christian Lunøe has stepped down as director of Re cph IVS.
As of February 3, 2016, Christian Lunøe is registered as director of Re cph IVS.
As of February 3, 2016, Jon Bjarke Kiellberg is registered as director of Re cph IVS.
Re cph IVS was founded on February 3, 2016.
